➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Moodys
McKinsey
Harvard Business School
Merck
Medtronic

Last Updated: June 19, 2021

DrugPatentWatch Database Preview

COSENTYX Drug Profile


Email this page to a colleague

« Back to Dashboard

Summary for Tradename: COSENTYX
Recent Clinical Trials for COSENTYX

Identify potential brand extensions & biosimilar entrants

SponsorPhase
Bio-Thera SolutionsPhase 1
Janssen Research & Development, LLCPhase 1
University of Erlangen-Nürnberg Medical SchoolPhase 3

See all COSENTYX clinical trials

Pharmacology for COSENTYX
Mechanism of ActionInterleukin-17A Antagonists

Patent Text Search: US Patents for COSENTYX

These patents were identified by searching patent claims

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Harvard Business School
AstraZeneca
Express Scripts
Mallinckrodt
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.